Drug
Bismuth Subcitrate Potassium, Metronidazole, And Tetracycline Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Faeces Discoloured | 80 | 69.7 | 75.0 | signal |
| 2 | Toxic Skin Eruption | 19 | 35.4 | 36.0 | signal |
| 3 | Chromaturia | 37 | 30.9 | 31.9 | signal |
| 4 | Helicobacter Infection | 16 | 29.6 | 30.0 | signal |
| 5 | Clostridium Difficile Colitis | 13 | 23.0 | 23.3 | signal |
| 6 | Hepatocellular Injury | 16 | 21.2 | 21.5 | signal |
| 7 | Face Oedema | 18 | 20.0 | 20.3 | signal |
| 8 | Thrombotic Microangiopathy | 8 | 15.5 | 15.6 | signal |
| 9 | Pharyngeal Oedema | 11 | 13.3 | 13.4 | signal |
| 10 | Vertigo | 43 | 13.3 | 13.8 | signal |
| 11 | Angioedema | 31 | 13.2 | 13.6 | signal |
| 12 | Renal Pain | 7 | 12.5 | 12.5 | signal |
| 13 | Melaena | 14 | 11.9 | 12.1 | signal |
| 14 | Pancreatitis Acute | 13 | 11.0 | 11.1 | signal |
| 15 | Cholestasis | 11 | 10.8 | 10.9 | signal |
| 16 | Oral Discomfort | 8 | 10.8 | 10.9 | signal |
| 17 | Tinnitus | 24 | 9.8 | 10.0 | signal |
| 18 | Clostridium Difficile Infection | 11 | 9.5 | 9.6 | signal |
| 19 | Diplopia | 13 | 9.4 | 9.5 | signal |
| 20 | Dysgeusia | 37 | 9.3 | 9.6 | signal |
| 21 | Eructation | 9 | 8.9 | 9.0 | signal |
| 22 | Impaired Driving Ability | 5 | 8.3 | 8.3 | signal |
| 23 | Pharyngeal Swelling | 4 | 7.9 | 7.9 | signal |
| 24 | Hepatic Cytolysis | 5 | 7.7 | 7.7 | signal |
| 25 | Rash Maculo-papular | 9 | 7.6 | 7.7 | signal |
| 26 | Blood Glucose Fluctuation | 4 | 6.8 | 6.9 | signal |
| 27 | Eosinophilia | 6 | 6.5 | 6.5 | signal |
| 28 | Rash Generalised | 9 | 6.4 | 6.5 | signal |
| 29 | Visual Acuity Reduced | 11 | 6.2 | 6.2 | signal |
| 30 | Product Dispensing Error | 7 | 6.1 | 6.1 | signal |
| 31 | Abdominal Pain Lower | 8 | 5.9 | 6.0 | signal |
| 32 | Incorrect Product Administration Duration | 6 | 5.6 | 5.6 | signal |
| 33 | Menstruation Delayed | 3 | 5.4 | 5.4 | signal |
| 34 | Neurotoxicity | 5 | 5.4 | 5.4 | signal |
| 35 | Inappropriate Schedule Of Drug Administration | 12 | 3.1 | 3.2 | signal |
| 36 | Circumstance Or Information Capable Of Leading To Medication Error | 5 | 2.8 | 2.8 | signal |